These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

793 related articles for article (PubMed ID: 26330355)

  • 1. Role of the Tumor Microenvironment in Breast Cancer.
    Soysal SD; Tzankov A; Muenst SE
    Pathobiology; 2015 Sep; 82(3-4):142-52. PubMed ID: 26330355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of tumor microenvironment in triple-negative breast cancer and its prognostic significance.
    Yu T; Di G
    Chin J Cancer Res; 2017 Jun; 29(3):237-252. PubMed ID: 28729775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-extracellular matrix interactions: Identification of tools associated with breast cancer progression.
    Giussani M; Merlino G; Cappelletti V; Tagliabue E; Daidone MG
    Semin Cancer Biol; 2015 Dec; 35():3-10. PubMed ID: 26416466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microenvironment in breast tumorigenesis: Friend or foe?
    Martins D; Schmitt F
    Histol Histopathol; 2019 Jan; 34(1):13-24. PubMed ID: 29978449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine disruptors and the tumor microenvironment: A new paradigm in breast cancer biology.
    Burks H; Pashos N; Martin E; Mclachlan J; Bunnell B; Burow M
    Mol Cell Endocrinol; 2017 Dec; 457():13-19. PubMed ID: 28012841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the Tumor Environment on Ion Channels: Implication for Breast Cancer Progression.
    Ouadid-Ahidouch H; Morjani H; Schnipper J; Girault A; Ahidouch A
    Rev Physiol Biochem Pharmacol; 2021; 181():1-38. PubMed ID: 32761457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity.
    Albini A; Bruno A; Gallo C; Pajardi G; Noonan DM; Dallaglio K
    Connect Tissue Res; 2015; 56(5):414-25. PubMed ID: 26291921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic crosstalk in the breast cancer microenvironment.
    Dias AS; Almeida CR; Helguero LA; Duarte IF
    Eur J Cancer; 2019 Nov; 121():154-171. PubMed ID: 31581056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insidious changes in stromal matrix fuel cancer progression.
    Miles FL; Sikes RA
    Mol Cancer Res; 2014 Mar; 12(3):297-312. PubMed ID: 24452359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural and Synthetic PPARγ Ligands in Tumor Microenvironment: A New Potential Strategy against Breast Cancer.
    Augimeri G; Gelsomino L; Plastina P; Giordano C; Barone I; Catalano S; Andò S; Bonofiglio D
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoprotein asporin as a novel player in tumour microenvironment and cancer progression.
    Simkova D; Kharaishvili G; Slabakova E; Murray PG; Bouchal J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Dec; 160(4):467-473. PubMed ID: 27605398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The microenvironment in breast cancer progression: biology and implications for treatment.
    Place AE; Jin Huh S; Polyak K
    Breast Cancer Res; 2011; 13(6):227. PubMed ID: 22078026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms governing metastatic dormancy in breast cancer.
    Dittmer J
    Semin Cancer Biol; 2017 Jun; 44():72-82. PubMed ID: 28344165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor microenvironment: driving forces and potential therapeutic targets for breast cancer metastasis.
    Xie HY; Shao ZM; Li DQ
    Chin J Cancer; 2017 Mar; 36(1):36. PubMed ID: 28356139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stroma: Role in osteosarcoma progression.
    Cortini M; Avnet S; Baldini N
    Cancer Lett; 2017 Oct; 405():90-99. PubMed ID: 28774797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fighting the force: Potential of homeobox genes for tumor microenvironment regulation.
    Northcott JM; Northey JJ; Barnes JM; Weaver VM
    Biochim Biophys Acta; 2015 Apr; 1855(2):248-53. PubMed ID: 25818365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proinvasive extracellular matrix remodeling for tumor progression.
    Kaushik N; Kim S; Suh Y; Lee SJ
    Arch Pharm Res; 2019 Jan; 42(1):40-47. PubMed ID: 30515725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Therapeutic Potential of Targeting Tumor Microenvironment in Breast Cancer: Rational Strategies and Recent Progress.
    Bahrami A; Hassanian SM; Khazaei M; Hasanzadeh M; Shahidsales S; Maftouh M; Ferns GA; Avan A
    J Cell Biochem; 2018 Jan; 119(1):111-122. PubMed ID: 28574616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the key roles of proteoglycans in breast cancer biology and translational medicine.
    Theocharis AD; Skandalis SS; Neill T; Multhaupt HA; Hubo M; Frey H; Gopal S; Gomes A; Afratis N; Lim HC; Couchman JR; Filmus J; Sanderson RD; Schaefer L; Iozzo RV; Karamanos NK
    Biochim Biophys Acta; 2015 Apr; 1855(2):276-300. PubMed ID: 25829250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated Bioinformatics Approach Reveals Crosstalk Between Tumor Stroma and Peripheral Blood Mononuclear Cells in Breast Cancer.
    He L; Wang D; Wei N; Guo Z
    Asian Pac J Cancer Prev; 2016; 17(3):1003-8. PubMed ID: 27039717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.